Abstract:Abnormal protein expression closely correlates with the occurrence and development of diseases. Thus, proteins have been widely used as disease markers for early diagnosis, treatment monitoring and prognosis evaluation of diseases. However, protein biomarkers in clinical samples are usually present in extremely low concentration while the detection often suffers from severe interference by high-abundance sample matrix, which challenges the specificity and sensitivity of protein biomarker assay methods. Currently, the main detection method of protein biomarkers is immunoassay. Nevertheless, immunoassay mainly relies on antibodies for specific recognition, and antibodies are associated with disadvantages such as difficulty in preparation, poor stability, and high-cost Meanwhile, immunoassay is mainly based on fluorescence and chemiluminescence to achieve high-sensitivity detection, but they have inherent defects such as cumbersome operation, photobleaching and broad spectrum. Molecularly imprinted polymers (MIP) have developed as biomimetic recognition materials with antibody-comparable specificity and affinity, while offering advantages such as ease in preparation, good stability and low cost. On the other hand, surface-enhanced Raman scattering (SERS) has been widely used in chemical or biological assays due to its merits including ultra-high sensitivity, narrow spectrum, speed, non-destructivity, and so on. In recent years, the combination of molecular imprinting and SERS has generated a series of advanced protein detection methods that exhibited unique strengths, which has gained wide attention. This review aims to survey the main advances of this hybrid analytical technique. After introduction of MCP and SERS as well as their separate applications in the detection of protein biomarkers, we mainly focus on the combination of MIP and SERS as well as its application in protein biomarker detection. We finally briefly sketch the future development of this hybrid analytical method.

[Application of ultrasensitive single molecule immunoassay technology in clinical biomarker detection]

Single-molecule immunoassay technology: Recent advances

Dynamic single-molecule sensing by actively tuning binding kinetics for ultrasensitive biomarker detection

Dynamic single-molecule sensing via nanoparticle micromanipulation for rapid and ultrasensitive biomarker detection

Label-free Single-molecule Immunoassay

Recent Advance in Single-Molecule Fluorescent Biosensors for Tumor Biomarker Detection

Single-Molecule Nanotechnologies: An Evolution In Biological Dynamics Detection

Biosensors Designed for Clinical Applications

Ultrasensitive Ambient Mass Spectrometry Immunoassays: Multiplexed Detection of Proteins in Serum and on Cell Surfaces.

Advances in Single Molecule Arrays (SIMOA) for Ultra-Sensitive Detection of Biomolecules

From Interface to Solution: Integrating Immunoassay with Netlike Rolling Circle Amplification for Ultrasensitive Detection of Tumor Biomarker

Emerging techniques for ultrasensitive protein analysis.

Review of Single-molecule Immunoassays: Non-chip and On-chip Assays

Advances in Nanoprobes‐based Immunoassays

Integrated Dual-Biomarker Detection: Transforming Proteins and Nucleic Acids into Ssdna for Enhanced Disease Diagnosis

Nanomaterials for Ultrasensitive Protein Detection

Advances in Protein Biomarker Assay Via the Combination of Molecular Imprinting and Surface-enhanced Raman Scattering

Ultrasensitive Assays for Proteins

Novel Methodologies in Analysis of Small Molecule Biomarkers and Living Cells

Integrated Single Microbead-Arrayed mu-Fluidic Platform for the Automated Detection of Multiplexed Biomarkers

Highly Sensitive and Multiplexed Mass Spectrometric Immunoassay Techniques and Clinical Applications.